Evidence map›Paper›PMID 41050446›Full record

ArticleFrontiers in bioengineering and biotechnology2025

Bayesian experimental design for optimizing medium composition and biomass formation of tobacco BY-2 cell suspension cultures in stirred-tank bioreactors.

Lars Leyendecker, Henrik Nausch, Christian Wergers, Dirk Scheffler, Robert H Schmitt

Abstract read
In one paragraph

Article in Frontiers in bioengineering and biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Lars Leyendecker *Department for Production Quality, Fraunhofer Institute for Production Technology IPT, Aachen, Germany.
Henrik Nausch *Department Model-Based Product and Bioprocess Engineering, Fraunhofer Institute for Molecular Biology and Applied Ecology IME, Aachen, Germany.
Christian WergersDepartment for Production Quality, Fraunhofer Institute for Production Technology IPT, Aachen, Germany.
Dirk SchefflerDepartment Model-Based Product and Bioprocess Engineering, Fraunhofer Institute for Molecular Biology and Applied Ecology IME, Aachen, Germany.
Robert H SchmittDepartment for Production Quality, Fraunhofer Institute for Production Technology IPT, Aachen, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: The plant suspension cell culture Bright Yellow-2 (BY-2) can be an economic platform for producing complex biopharmaceuticals like cytokines and antibodies at small- and medium-scale because of potentially reduced cultivation and purification costs compared to mammalian cells. This is especially relevant for rare diseases. However, the productivity is currently low in terms of biomass formation in a typical batch fermentation. A potential reason might be that the standard BY-2 cultivation medium, as it is used under laboratory shake-flask cultivation conditions, has not yet been comprehensively optimized and tested in industrial bioreactor settings, addressing all four macronutrients relevant for biomass formation (i.e., sucrose, ammonium, nitrate, and phosphate) in parallel. In this article, we therefore propose a multi-variate, multi-objective, and batch-wise Bayesian experimental design (BED) approach for optimally parameterizing macronutrient supply in the cultivation medium, promoting the fresh mass (FM) increase (i.e., growth rate) and final FM (i.e., biomass). Methods: We performed a sequential and adaptive experimentation utilizing the BED to optimize the cultivation medium in four iterations with four different media each and confirmed the results in two additional experimentation rounds. Results: Our results show that while nitrate and phosphate can be used to adjust the growth rate (i.e., reaching up to 40 g/L × d FM), it is possible to reduce sucrose and ammonium without impacting the growth rate and only affecting the final biomass yield (i.e., reaching up to 300 g/L FM). Thereby, we improved the overall productivity of biomass formation (i.e., as a ratio between nutrient and FM input and FM output) for this batch fermentation process by 36%. Discussion: The results demonstrate the advantages of BED to generate new medium compositions (i.e., macronutrient concentrations) by unbiasedly varying the design space. Thereby, the discovery of new process insights (i.e., impact of individual macronutrient concentrations on the growth rate and biomass formation) is facilitated. Moreover, we show that our data-efficient and black-box BED approach represents a promising alternative to traditional design of experiments (DoE) and mechanistic white-box modeling. Established for the plant suspension cell line BY-2, our BED approach might also apply to yeast and mammalian cells.

Indexed as

batch fermentationBayesian optimizationbiopharmaceuticalsprocess optimizationupstream production

Identifiers

PMID41050446
PMCPMC12492029

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.